Zoetis Inc. $ZTS Shares Purchased by River Street Advisors LLC

River Street Advisors LLC increased its stake in shares of Zoetis Inc. (NYSE:ZTS) by 33.3% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 3,614 shares of the company’s stock after acquiring an additional 903 shares during the quarter. River Street Advisors LLC’s holdings in Zoetis were worth $564,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the stock. Nova Wealth Management Inc. acquired a new position in shares of Zoetis during the 1st quarter valued at about $25,000. 1248 Management LLC acquired a new position in Zoetis in the 1st quarter valued at about $27,000. Saudi Central Bank purchased a new stake in shares of Zoetis in the 1st quarter valued at approximately $29,000. Cornerstone Planning Group LLC increased its holdings in shares of Zoetis by 79.3% during the 1st quarter. Cornerstone Planning Group LLC now owns 199 shares of the company’s stock worth $30,000 after buying an additional 88 shares during the last quarter. Finally, ORG Partners LLC raised its position in shares of Zoetis by 56.8% during the 2nd quarter. ORG Partners LLC now owns 232 shares of the company’s stock valued at $37,000 after buying an additional 84 shares during the period. 92.80% of the stock is currently owned by hedge funds and other institutional investors.

Zoetis Stock Down 0.3%

Zoetis stock opened at $146.46 on Friday. The firm has a market capitalization of $64.91 billion, a P/E ratio of 25.21, a P/E/G ratio of 2.36 and a beta of 0.90. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 1.05. Zoetis Inc. has a twelve month low of $139.34 and a twelve month high of $196.55. The stock’s fifty day simple moving average is $149.89 and its 200-day simple moving average is $155.26.

Zoetis (NYSE:ZTS) last released its earnings results on Tuesday, August 5th. The company reported $1.76 EPS for the quarter, topping the consensus estimate of $1.62 by $0.14. The firm had revenue of $2.46 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.Zoetis’s revenue for the quarter was up 4.2% on a year-over-year basis. During the same period in the previous year, the firm posted $1.56 EPS. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, equities analysts expect that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have issued reports on ZTS. Leerink Partnrs cut Zoetis from a “strong-buy” rating to a “hold” rating in a research note on Thursday, July 17th. Piper Sandler raised their price objective on Zoetis from $210.00 to $215.00 and gave the stock an “overweight” rating in a research report on Monday, August 11th. Argus reaffirmed a “buy” rating and issued a $190.00 target price on shares of Zoetis in a research report on Tuesday, September 9th. Leerink Partners cut shares of Zoetis from an “outperform” rating to a “market perform” rating and dropped their price target for the company from $180.00 to $155.00 in a research report on Thursday, July 17th. Finally, Stifel Nicolaus lowered shares of Zoetis from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $165.00 to $160.00 in a report on Wednesday, June 18th. Five equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $200.88.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.